BacterioScan, Inc.
PrivateLast Round
Bankruptcy
Nov 15, 2021
Total Funding Raised
$8.61M
Company Overview
BacterioScan, Inc. operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Debt round in April 2020.
BacterioScan, Inc. is a medical device company that develops rapid diagnostic technology for the detection and quantification of bacteria in fluid samples.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BacterioScan, Inc. Comparables
Compare BacterioScan, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sansure Biotech Inc. | 79% | |
| FluoretiQ | 78% | |
| Astek Diagnostics | 77% |
For institutional investors. Book with your work email.
BacterioScan, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Bankruptcy | Nov 15, 2021 | ||||
| Debt | Apr 29, 2020 | ||||
| VC Round | Aug 7, 2015 | ||||
| Series A | Dec 11, 2014 | ||||
| Seed | May 20, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BacterioScan, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Missouri Technology Corporation | Series A |
| St. Louis Arch Angels | Seed, VC Round |
| BioGenerator Ventures | Series A |
| Warson Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 1286% MoM.
- Jan 2, 2026
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
BacterioScan, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BacterioScan, Inc.'s valuation, stock price, and market status.
Is BacterioScan, Inc. a public or private company?
BacterioScan, Inc. is a private company.
What is the current stock price of BacterioScan, Inc.?
BacterioScan, Inc. is a private company, so its shares have no public market price. Caplight tracks BacterioScan, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BacterioScan, Inc. worth (valuation)?
Valuation information for BacterioScan, Inc. is not publicly available.
Can I buy BacterioScan, Inc. stock?
BacterioScan, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BacterioScan, Inc.'s last funding round?
BacterioScan, Inc.'s most recent funding round was Bankruptcy on November 15, 2021.
Who are the main investors in BacterioScan, Inc.?
Key investors in BacterioScan, Inc. include Warson Capital Partners.
Will BacterioScan, Inc. IPO soon?
No public IPO plans have been announced for BacterioScan, Inc..
How can I track BacterioScan, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BacterioScan, Inc.'s shares on secondary markets.